Morning Briefing
Summaries of health policy coverage from major news organizations
Lobbyists Battle Over Biologic Drug Protections
"As Congress struggles with a massive health care overhaul, several lobbying powerhouses - including the pharmaceutical industry and the nation's largest advocacy group for retirees - are locked in a contentious fight over the future of biotechnology drugs," USA Today reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
